These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 21149740)
1. Inactivation of p53 in breast cancers correlates with stem cell transcriptional signatures. Mizuno H; Spike BT; Wahl GM; Levine AJ Proc Natl Acad Sci U S A; 2010 Dec; 107(52):22745-50. PubMed ID: 21149740 [TBL] [Abstract][Full Text] [Related]
2. MDM2 Associates with Polycomb Repressor Complex 2 and Enhances Stemness-Promoting Chromatin Modifications Independent of p53. Wienken M; Dickmanns A; Nemajerova A; Kramer D; Najafova Z; Weiss M; Karpiuk O; Kassem M; Zhang Y; Lozano G; Johnsen SA; Moll UM; Zhang X; Dobbelstein M Mol Cell; 2016 Jan; 61(1):68-83. PubMed ID: 26748827 [TBL] [Abstract][Full Text] [Related]
3. Abrogation of p53 function leads to metastatic transcriptome networks that typify tumor progression in human breast cancer xenografts. D'Assoro AB; Leontovich A; Amato A; Ayers-Ringler JR; Quatraro C; Hafner K; Jenkins RB; Libra M; Ingle J; Stivala F; Galanis E; Salisbury JL Int J Oncol; 2010 Nov; 37(5):1167-76. PubMed ID: 20878064 [TBL] [Abstract][Full Text] [Related]
4. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells. Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355 [TBL] [Abstract][Full Text] [Related]
5. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer. Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438 [TBL] [Abstract][Full Text] [Related]
6. High GINS2 transcript level predicts poor prognosis and correlates with high histological grade and endocrine therapy resistance through mammary cancer stem cells in breast cancer patients. Zheng M; Zhou Y; Yang X; Tang J; Wei D; Zhang Y; Jiang JL; Chen ZN; Zhu P Breast Cancer Res Treat; 2014 Nov; 148(2):423-36. PubMed ID: 25348432 [TBL] [Abstract][Full Text] [Related]
7. Bmi-1, stem cells and cancer. Jiang L; Li J; Song L Acta Biochim Biophys Sin (Shanghai); 2009 Jul; 41(7):527-34. PubMed ID: 19578716 [TBL] [Abstract][Full Text] [Related]
13. Gain of oncogenic function of p53 mutants induces invasive phenotypes in human breast cancer cells by silencing CCN5/WISP-2. Dhar G; Banerjee S; Dhar K; Tawfik O; Mayo MS; Vanveldhuizen PJ; Banerjee SK Cancer Res; 2008 Jun; 68(12):4580-7. PubMed ID: 18559502 [TBL] [Abstract][Full Text] [Related]
14. Pan-Cancer Molecular Patterns and Biological Implications Associated with a Tumor-Specific Molecular Signature. Rocha D; García IA; González Montoro A; Llera A; Prato L; Girotti MR; Soria G; Fernández EA Cells; 2020 Dec; 10(1):. PubMed ID: 33396205 [TBL] [Abstract][Full Text] [Related]
15. Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status. Bouchalova P; Nenutil R; Muller P; Hrstka R; Appleyard MV; Murray K; Jordan LB; Purdie CA; Quinlan P; Thompson AM; Vojtesek B; Coates PJ J Pathol; 2014 Jul; 233(3):238-46. PubMed ID: 24687952 [TBL] [Abstract][Full Text] [Related]
16. The R246S hot-spot p53 mutant exerts dominant-negative effects in embryonic stem cells in vitro and in vivo. Lee MK; Sabapathy K J Cell Sci; 2008 Jun; 121(11):1899-906. PubMed ID: 18477611 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Shimono Y; Zabala M; Cho RW; Lobo N; Dalerba P; Qian D; Diehn M; Liu H; Panula SP; Chiao E; Dirbas FM; Somlo G; Pera RA; Lao K; Clarke MF Cell; 2009 Aug; 138(3):592-603. PubMed ID: 19665978 [TBL] [Abstract][Full Text] [Related]
18. p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin. Megha T; Ferrari F; Benvenuto A; Bellan C; Lalinga AV; Lazzi S; Bartolommei S; Cevenini G; Leoncini L; Tosi P J Clin Pathol; 2002 Jun; 55(6):461-6. PubMed ID: 12037031 [TBL] [Abstract][Full Text] [Related]
19. p53 gene mutations and expression of p53 and mdm2 proteins in invasive breast carcinoma. A comparative analysis with clinico-pathological factors. Günther T; Schneider-Stock R; Rys J; Niezabitowski A; Roessner A J Cancer Res Clin Oncol; 1997; 123(7):388-94. PubMed ID: 9260591 [TBL] [Abstract][Full Text] [Related]
20. p53 is active in murine stem cells and alters the transcriptome in a manner that is reminiscent of mutant p53. Yan H; Solozobova V; Zhang P; Armant O; Kuehl B; Brenner-Weiss G; Blattner C Cell Death Dis; 2015 Feb; 6(2):e1662. PubMed ID: 25719246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]